Primiano Christopher Brett
Insider CIK 1603510 · AURA Chief Business Officer · KPTI VP, GEN COUNSEL & SECRETARY
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences, Inc. | A Award deriv | 2021-10-28 | 2021-10-29 | 37,500 | — | $0 | 37,500 | SEC↗ |
| AURA Aura Biosciences, Inc. | A Award | 2021-10-28 | 2021-10-29 | 8,750 | — | $0 | 8,750 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-12-01 | 2020-12-03 | 78,124 | — | $0 | 46,876 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-12-01 | 2020-12-03 | 58,937 | — | $0 | 16,842 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-12-01 | 2020-12-03 | 78,124 | $17.66 | $1.38M | 4,523 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-12-01 | 2020-12-03 | 78,124 | $10.45 | $816.4K | 82,647 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-12-01 | 2020-12-03 | 58,937 | $10.39 | $612.4K | 63,460 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-12-01 | 2020-12-03 | 58,937 | $17.35 | $1.02M | 4,523 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-11-02 | 2020-11-04 | 772 | $14.92 | $11.5K | 4,523 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-10-13 | 2020-10-14 | 38,550 | — | $0 | 64,250 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-10-13 | 2020-10-14 | 721 | — | $0 | 75,779 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-10-13 | 2020-10-14 | 38,550 | $9.21 | $355.0K | 43,199 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-10-13 | 2020-10-14 | 38,550 | $16.85 | $649.6K | 4,649 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-10-13 | 2020-10-14 | 721 | $10.39 | $7.5K | 5,370 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-10-13 | 2020-10-14 | 721 | $17.20 | $12.4K | 4,649 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-09-08 | 2020-09-10 | 10,054 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-09-08 | 2020-09-10 | 10,054 | $6.54 | $65.8K | 14,703 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-09-08 | 2020-09-10 | 10,054 | $14.98 | $150.6K | 4,649 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-05-07 | 2020-05-11 | 2,946 | — | $0 | 10,054 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-05-07 | 2020-05-11 | 2,946 | $20.00 | $58.9K | 4,649 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-05-07 | 2020-05-11 | 6,714 | $19.62 | $131.7K | 4,649 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-05-07 | 2020-05-11 | 2,946 | $6.54 | $19.3K | 7,595 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-03-02 | 2020-03-04 | 26,500 | — | $0 | 76,500 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-02 | 2020-03-04 | 7,500 | $23.50 | $176.3K | 29,367 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-02 | 2020-03-04 | 10,000 | $28.00 | $280.0K | 19,367 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-03-02 | 2020-03-04 | 9,000 | $24.00 | $216.0K | 10,367 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-03-02 | 2020-03-04 | 26,500 | $10.39 | $275.3K | 36,867 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2020-02-19 | 2020-02-21 | 2,961 | $16.48 | $48.8K | 10,367 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2020-02-15 | 2020-02-19 | 9,675 | — | $0 | 29,025 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2020-02-15 | 2020-02-19 | 9,675 | — | $0 | 13,328 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 81,200 | — | $0 | 81,200 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 30,300 | — | $0 | 30,300 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-27 | 2019-12-31 | 5,000 | — | $0 | 103,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-27 | 2019-12-31 | 5,000 | $10.39 | $52.0K | 8,653 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-27 | 2019-12-31 | 5,000 | $20.00 | $100.0K | 3,653 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-06 | 2019-12-10 | 5,000 | — | $0 | 108,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2019-12-06 | 2019-12-10 | 5,000 | — | $0 | 13,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-06 | 2019-12-10 | 3,000 | $17.46 | $52.4K | 3,653 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-06 | 2019-12-10 | 5,000 | $6.54 | $32.7K | 11,653 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-06 | 2019-12-10 | 5,000 | $17.45 | $87.3K | 6,653 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2019-12-06 | 2019-12-10 | 5,000 | $17.46 | $87.3K | 11,653 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2019-12-06 | 2019-12-10 | 5,000 | $10.39 | $52.0K | 16,653 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 38,700 | — | $0 | 38,700 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-15 | 2019-02-19 | 102,800 | — | $0 | 102,800 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-09-10 | 2018-09-11 | 5,000 | — | $0 | 113,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2018-09-10 | 2018-09-11 | 5,000 | — | $0 | 18,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-09-10 | 2018-09-11 | 5,000 | $10.39 | $52.0K | 12,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-09-10 | 2018-09-11 | 10,000 | $18.90 | $189.0K | 2,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2018-09-10 | 2018-09-11 | 5,000 | $6.54 | $32.7K | 7,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-05-10 | 2018-05-10 | 2,000 | $18.01 | $36.0K | 2,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-03-05 | 2018-03-06 | 2,500 | $16.03 | $40.1K | 4,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-02-16 | 2018-02-20 | 1,486 | $15.01 | $22.3K | 7,381 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-02-15 | 2018-02-20 | 1,014 | $15.02 | $15.2K | 8,867 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2018-02-07 | 2018-02-08 | 1,500 | $13.00 | $19.5K | 9,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2018-01-24 | 2018-01-25 | 125,000 | — | $0 | 125,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2017-12-12 | 2017-12-13 | 17,000 | — | $0 | 23,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-12-12 | 2017-12-13 | 644 | $9.59 | $6.2K | 11,381 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2017-12-12 | 2017-12-13 | 17,000 | $6.54 | $111.2K | 28,381 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-12-12 | 2017-12-13 | 16,356 | $9.93 | $162.4K | 12,025 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-12-11 | 2017-12-13 | 10,042 | $10.88 | $109.3K | 11,381 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-11-07 | 2017-11-09 | 4,958 | $11.25 | $55.8K | 21,423 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2017-11-05 | 2017-11-06 | 15,000 | — | $0 | 0 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2017-11-05 | 2017-11-06 | 15,000 | — | $0 | 26,381 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-10-02 | 2017-10-04 | 1,500 | $12.00 | $18.0K | 11,381 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-09-15 | 2017-09-18 | 2,000 | $11.00 | $22.0K | 12,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-08-29 | 2017-08-30 | 2,195 | $10.00 | $21.9K | 15,686 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2017-06-26 | 2017-09-01 | 805 | $10.03 | $8.1K | 14,881 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2017-01-20 | 2017-01-24 | 118,000 | — | $0 | 118,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2016-11-09 | 2016-11-14 | 4,342 | $8.19 | $35.6K | 15,819 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2016-11-05 | 2016-11-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2016-11-05 | 2016-11-08 | 15,000 | — | $0 | 20,161 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2016-01-15 | 2016-01-20 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-11-05 | 2015-11-09 | 30,000 | — | $0 | 30,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-09-18 | 2015-09-21 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2015-01-19 | 2015-01-22 | 125,000 | — | $0 | 125,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | P Buy | 2014-05-13 | 2014-05-13 | 1,000 | $26.75 | $26.8K | 1,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2014-04-16 | 2014-04-17 | 75,000 | — | $0 | 75,000 | SEC↗ |